Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Appropriations bill

This article was originally published in The Tan Sheet

Executive Summary

A resolution to the Agriculture, Rural Development, FDA & Related Agencies Appropriations bill for fiscal 2006 mandates that members of FDA advisory committees disclose conflicts of interest no later than 15 days prior to meetings in order to receive waivers, according to a House conference report issued Oct. 28. Congress approved a measure by Rep. Maurice Hinchey (D-N.Y.) in June that would have stopped funding for waivers, thus preventing scientists and doctors with conflicts of interest from participating on committees (1"The Tan Sheet" June 13, 2005, p. 10). The Senate revamped the language in September to approve a less stringent measure; the Senate language serves as the foundation for the conference version, which "says to the FDA...if you want to continue using doctors and scientists with conflicts of interest, go right ahead, just let us know about it," Hinchey said. "That's unacceptable"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098768

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel